Beijing Tongrentang (600085.SH): Multiple products receive Canadian product licenses.
Tongrentang (600085.SH) announced that its subsidiary Beijing Tongrentang Pharmaceutical Co., Ltd. has received the "Product License (Class Three)" issued by Health Canada. The products Er Gan Qing Oral Liquid, Suo Yang Gu Jing Pill, Ren Shen Jian Pi Pill, and Da Huang Jiachong Pill from Tongrentang Pharmaceutical Co. have been registered in Canada.
Beijing Tongrentang (600085.SH) announced that its subsidiary, Beijing Tongrentang Pharmaceutical Factory, has received approval from the Canadian Health Department for a Product License (Class III). The products of Beijing Tongrentang Pharmaceutical Factory, including Er Gan Qing Oral Liquid, Suo Yang Gu Jing Pill, Ren Shen Jian Pi Pill, and Da Huang Wei Chong Pill, have been registered in Canada.
The issuance of the Product License (Class III) by the Canadian Health Department allows the above-mentioned products to be marketed in Canada. However, in order to sell these products in Canada, the company will still need to complete administrative approval procedures in accordance with Canadian regulations, which may include obtaining Canadian production quality system certification for the manufacturing site, among other requirements. There may be some uncertainty in the approval process.
The approval of these products is not expected to have a significant impact on the company's recent business performance.
Related Articles

On February 24th, XD INC (02400) spent 4.9054 million Hong Kong dollars to repurchase 65,000 shares.

Huiyu Pharmaceutical (688553.SH) passed the on-site inspection by the U.S. FDA.

On February 24, Taiwan (09890) spent HK$14.757 million to repurchase 750,000 shares.
On February 24th, XD INC (02400) spent 4.9054 million Hong Kong dollars to repurchase 65,000 shares.

Huiyu Pharmaceutical (688553.SH) passed the on-site inspection by the U.S. FDA.

On February 24, Taiwan (09890) spent HK$14.757 million to repurchase 750,000 shares.

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


